Page last updated: 2024-09-03

b 4162 and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

b 4162 has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies

Compound Research Comparison

Studies
(b 4162)
Trials
(b 4162)
Recent Studies (post-2010)
(b 4162)
Studies
(15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)
Trials
(15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)
Recent Studies (post-2010) (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)
50102,57727327

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asghar, AU; Bountra, C; Coleman, RA; McQueen, DS; Wheeldon, A1

Other Studies

1 other study(ies) available for b 4162 and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

ArticleYear
Hoe 140 and pseudo-irreversible antagonism in the rat vas deferens in vitro.
    European journal of pharmacology, 2000, Jun-09, Volume: 398, Issue:1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Bradykinin; Bradykinin Receptor Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Rats; Rats, Wistar; Vas Deferens

2000